Balance Sheet

Currency: USD

	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	92	436	364	356	394	377	376	681
Cash Equivalents	92	436	364	356	394	377	376	681
Short-Term Investments	0	0	182	251	443	95	59	0
Total Receivables	0	0	0	0	0	0	0	5
Accounts Receivables	0	0	0	0	0	0	0	5
Other Receivables	0	0	0	0	0	0	0	0
Other Current Assets	5	9	23	36	52	77	43	35
Total Current Assets	97	445	569	643	889	549	478	721
PP&E Net	0	2	6	37	46	25	20	13
PP&E Gross	0	2	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	45	29	26	24
Long-Term Investments	0	17	31	0	0	0	59	144
Other Long-Term Assets	1	1	26	24	33	20	23	18
Total Assets	98 N/A	465 +374%	632 +36%	704 +11%	1 013 +44%	623 -38%	546 -12%	919 +68%
Liabilities
Accounts Payable	2	14	9	9	12	12	11	10
Accrued Liabilities	6	15	48	80	123	102	127	130
Short-Term Debt	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	2	0	0	0	0
Other Current Liabilities	1	4	4	6	0	8	6	15
Total Current Liabilities	9	33	60	96	135	121	144	154
Long-Term Debt	0	55	92	477	1 705	1 708	1 727	2 200
Minority Interest	3	63	68	50	5	10	12	10
Other Liabilities	0	1	4	23	38	39	18	22
Total Liabilities	12 N/A	150 +1 130%	223 +49%	646 +189%	1 883 +192%	1 878 0%	1 901 +1%	2 387 +26%
Equity
Common Stock	147	482	0	0	0	0	0	0
Retained Earnings	61	167	440	889	1 437	1 918	2 561	3 096
Additional Paid In Capital	0	0	848	1 021	842	939	1 481	1 903
Treasury Stock	0	0	0	75	275	275	275	275
Other Equity	0	0	0	0	0	0	0	0
Total Equity	86 N/A	315 +267%	409 +30%	58 -86%	870 N/A	1 255 -44%	1 354 -8%	1 468 -8%
Total Liabilities & Equity	98 N/A	465 +374%	632 +36%	704 +11%	1 013 +44%	623 -38%	546 -12%	919 +68%
Shares Outstanding
Common Shares Outstanding	115	115	124	123	147	151	175	190

BridgeBio Pharma Inc
NASDAQ:BBIO